Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali

Background. In 2010, Africa's first preventive meningococcal mass vaccination campaign was launched using a newly developed Neisseria meningitidis group A (NmA) polysaccharide–tetanus toxoid conjugate vaccine, PsA-TT (MenAfriVac), designed specifically for the meningitis belt. Given PsA-TT'...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Infect Dis
Auteurs principaux: Basta, Nicole E., Borrow, Ray, Berthe, Abdoulaye, Dembélé, Awa Traoré Eps, Onwuchekwa, Uma, Townsend, Kelly, Boukary, Rahamatou M., Mabey, Lesley, Findlow, Helen, Bai, Xilian, Sow, Samba O.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2015
Sujets:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639504/
https://ncbi.nlm.nih.gov/pubmed/26553687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ602
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires